Project Grant R01MH140223
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Trustees of Columbia University in the City of New York a Project Grant of $126,900 under the Mental Health Research Grants program (CFDA 93.242) for research extending from April 2, 2026, through March 31, 2028. This award funds basic neuroscience research investigating the cellular and circuit mechanisms underlying value representation in the mouse medial prefrontal cortex (mPFC), a brain region essential...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $844,917 under the Mental Health Research Grants program (CFDA 93.242), effective July 1, 2025, through April 30, 2030. The project, titled "Moderate Effect Size Genes in Autism Spectrum Disorder," delivers research services focused on identifying and characterizing moderate effect size (MES) risk genes that contribute to autism spectrum...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a Project Grant totaling $183,118 on September 1, 2025, under the Mental Health Research Grants program (CFDA 93.242). Under the direction of Dr. Tubbs, this research initiative will deliver integrated genomic and electronic health record (EHR) analyses designed to advance precision psychiatry by addressing critical gaps in translating genetic findings to clinical practice. The...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Feinstein Institutes for Medical Research a Project Grant of $519,558 under the Mental Health Research Grants program (CFDA 93.242), effective June 15, 2025 through April 30, 2030. The research project focuses on identifying and validating cerebellar-cortical circuitry biomarkers as predictive indicators of antipsychotic treatment response in first-episode psychosis patients. The primary deliverables...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $394,200 to the Research Foundation For Mental Hygiene, Inc. (through its New York State Psychiatric Institute division) under the Mental Health Research Grants program (CFDA 93.242) on August 1, 2025, for a five-year project period extending through July 31, 2030. This Project Grant funds a clinical research study examining the role of the anterior hippocampus in major depressive disorder (MDD) pathogenesis....
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Southern California $654,923 on September 1, 2025, under the Mental Health Research Grants program (CFDA 93.242) to establish ENIGMA CentileBrain, a normative modeling framework for brain health and disease. This five-year initiative (through June 30, 2030) will develop and disseminate the largest public-access platform of normative models for multimodal neuroimaging measures, including...
- Federal Grant Award Summary The Feinstein Institutes for Medical Research received a $1,659,568 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded June 2, 2025, with completion targeted for May 31, 2030. The award funds the ESPRITO EPINET project, which aims to expand a learning health system (LHS) framework for improving treatment outcomes in early first-episode psychosis (FEP) care. The project will enroll an...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded a Project Grant totaling $778,548 to the Research Foundation For Mental Hygiene, Inc., operating through its Nathan S Kline Institute for Psychiatric Research, under the Mental Health Research Grants program (CFDA 93.242). The award, effective September 19, 2025, through July 31, 2030, supports research investigating sensory contributions to third visual pathway (TVP) dysfunction in schizophrenia, with a...
- The National Institute of Mental Health (NIMH) awarded a $412,500 Project Grant to Massachusetts General Hospital's Research Management Division effective September 1, 2025 through August 31, 2027, under the Mental Health Research Grants program (CFDA 93.242). The grant supports development of a copy number variant (CNV) discovery pipeline optimized for integrated genome-exome sequencing analysis. The project addresses a critical gap in neuropsychiatric research by creating computational tools...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Johns Hopkins University a $197,640 Project Grant effective September 1, 2025 through August 31, 2030 under the Mental Health Research Grants program (CFDA 93.242). This five-year award supports an early-career investigator's research into schizophrenia-associated genetic variants in the GRIA3 gene, which encodes GluA3, a critical subunit of the AMPA receptor (Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid...
The National Institute of Mental Health (NIMH) awarded a Project Grant of $534,191 to The Trustees of Columbia University in the City of New York (Health Sciences Division) effective April 1, 2026, through December 31, 2030, under the Mental Health Research Grants program (CFDA 93.242). This award funds the development of novel genetic discovery methodologies for neuropsychiatric traits, specifically addressing the complexity of causal variant identification across genetically diverse populations. The research project will develop robust fine-mapping tools designed to account for heterogeneity in effect sizes and linkage disequilibrium structure across populations of varying geographic origins, addressing a critical gap in psychiatric genetic research where existing methods produce suboptimal power and can prioritize non-causal variants. The project directly supports NIMH's mission to transform understanding and treatment of mental illnesses through basic and clinical research by leveraging deep phenotype data from major neuropsychiatric genetics initiatives including the Latin American Genomics Consortium, Genomics of Autism in Latino Ancestries, Ancestral Population Network, and PsychEmerge. By developing methodologies that properly model population heterogeneity and account for correlations across geographic origins, the research will enhance the transferability of genetic discoveries across diverse populations and improve understanding of disease pathophysiology in autism spectrum disorder, bipolar disorder, schizophrenia, and related neuropsychiatric conditions.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $534.2k | 4/17/26 |